Primary Site >> Stomach Cancer

Gene >> DPYD

1.
Journal: J Clin Oncol. 1998 Aug;16(8):2877-85.
Title: Uracil-tegafur in gastric carcinoma: a comprehensive review.
Author: Takiuchi, H|Ajani, J A
PMID: 9704742
2.
Journal: Eur J Cancer. 1998 Oct;34(11):1715-20.
Title: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
Author: Sakata, Y|Ohtsu, A|Horikoshi, N|Sugimachi, K|Mitachi, Y|Taguchi, T
PMID: 9893658
3.
Journal: Clin Cancer Res. 1999 Apr;5(4):883-9.
Title: Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
Author: Ishikawa, Y|Kubota, T|Otani, Y|Watanabe, M|Teramoto, T|Kumai, K|Kitajima, M|Takechi, T|Okabe, H|Fukushima, M
PMID: 10213225
4.
Journal: Clin Cancer Res. 1999 Aug;5(8):2000-5.
Title: Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Author: Hirata, K|Horikoshi, N|Aiba, K|Okazaki, M|Denno, R|Sasaki, K|Nakano, Y|Ishizuka, H|Yamada, Y|Uno, S|Taguchi, T|Shirasaka, T
PMID: 10473078
5.
Journal: Anticancer Res. 1999 Nov-Dec;19(6C):5635-40.
Title: Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
Author: Ishikawa, Y|Kubota, T|Otani, Y|Watanabe, M|Teramoto, T|Kumai, K|Takechi, T|Okabe, H|Fukushima, M|Kitajima, M
PMID: 10697632
6.
Journal: Jpn J Cancer Res. 2000 Jan;91(1):105-12.
Title: Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.
Author: Ishikawa, Y|Kubota, T|Otani, Y|Watanabe, M|Teramoto, T|Kumai, K|Takechi, T|Okabe, H|Fukushima, M|Kitajima, M
PMID: 10744051
7.
Journal: Int J Oncol. 2000 Jul;17(1):33-8.
Title: Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.
Author: Mori, K|Hasegawa, M|Nishida, M|Toma, H|Fukuda, M|Kubota, T|Nagasue, N|Yamana, H|Hirakawa-YS Chung, K|Ikeda, T|Takasaki, K|Oka, M|Kameyama, M|Toi, M|Fujii, H|Kitamura, M|Murai, M|Sasaki, H|Ozono, S|Makuuchi, H|Shimada, Y|Onishi, Y|Aoyagi, S|Mizutani, K|Oga
PMID: 10853015
8.
Journal: Anticancer Res. 2000 Jul-Aug;20(4):2457-62.
Title: 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer.
Author: Inada, T|Ogata, Y|Kubota, T|Tomikawa, M|Yamamoto, S|Andoh, J|Ozawa, I|Hishinuma, S|Shimizu, H|Kotake, K
PMID: 10953310
9.
Journal: Int J Oncol. 2000 Oct;17(4):653-8.
Title: Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1). Study Group of S-1 for Gastric Cancer.
Author: Miyamoto, S|Boku, N|Ohtsu, A|Yoshida, S|Ochiai, A|Okabe, H|Fukushima, M
PMID: 10995874
10.
Journal: Gan To Kagaku Ryoho. 2000 Nov;27(13):2043-7.
Title: [Recent advance in gastric cancer chemotherapy].
Author: Kubota, T
PMID: 11103235
11.
Journal: Gan To Kagaku Ryoho. 2001 May;28(5):649-54.
Title: [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers].
Author: Tsukayama, S|Hirano, M|Murakami, N|Uno, Y|Nozawa, H|Yoshino, H|Orta, N|Kikkawa, H|Masuda, S
PMID: 11383213
12.
Journal: Int J Oncol. 2001 Aug;19(2):341-6.
Title: Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion.
Author: Uchida, K|Hayashi, K|Kuramochi, H|Takasaki, K
PMID: 11445849
13.
Journal: Jpn J Cancer Res. 2001 Oct;92(10):1127-32.
Title: High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro.
Author: Habara, K|Ajiki, T|Kamigaki, T|Nakamura, T|Kuroda, Y
PMID: 11676864
14.
Journal: Gan To Kagaku Ryoho. 2002 Jan;29(1):119-23.
Title: [A complete response after neoadjuvant chemotherapy for advanced gastric cancer with esophageal invasion].
Author: Yabusaki, Hiroshi|Nashimoto, Atsushi|Tanaka, Otsuo
PMID: 11816467
15.
Journal: Gan To Kagaku Ryoho. 2002 Feb;29(2):245-52.
Title: [Dihydropyrimidine dehydrogenase expression in gastric cancer using anti-human dihydropyrimidine dehydrogenase monoclonal antibody].
Author: Kitago, Kuniaki|Ichikawa, Wataru|Uetake, Hiroyuki|Nihei, Zenro
PMID: 11865631
16.
Journal: Cancer Chemother Pharmacol. 2002 Apr;49(4):267-73.
Title: Dihydropyrimidine dehydrogenase expression in preoperative biopsy and surgically resected specimens of gastric carcinoma.
Author: Nozawa, Hiroaki|Tsukui, Hajime|Nishida, Koichiro|Yakumaru, Kazuhiro|Nagawa, Hirokazu|Sekikawa, Takayoshi
PMID: 11914904
17.
Journal: Anticancer Drugs. 2002 Apr;13(4):411-6.
Title: Dihydropyrimidine dehydrogenase-related enzymes predict efficacy and adverse reactions of UFT1+cisplatin neoadjuvant chemotherapy for gastric cancer.
Author: Takiguchi, Nobuhiro|Koda, Keiji|Ooshima, Hirokazu|Oda, Kenji|Suzuki, Hirofumi|Ishii, Rumiko|Miyazaki, Masaru
PMID: 11984087
18.
Journal: Anticancer Res. 2002 Mar-Apr;22(2A):761-8.
Title: Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
Author: Terashima, M|Irinoda, T|Fujiwara, H|Nakaya, T|Takagane, A|Abe, K|Yonezawa, H|Oyama, K|Inaba, T|Saito, K|Takechi, T|Fukushima, M
PMID: 12014648
19.
Journal: Cancer Chemother Pharmacol. 2002 Jul;50(1):25-32.
Title: Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function.
Author: Ikeda, Masataka|Furukawa, Hiroshi|Imamura, Hiroshi|Shimizu, Jyunzo|Ishida, Hideyuki|Masutani, Seizo|Tatsuta, Masayuki|Kawasaki, Takatoshi|Satomi, Takashi
PMID: 12111108
20.
Journal: Eur J Cancer. 2002 Dec;38(18):2375-81.
Title: Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients.
Author: Terashima, M|Fujiwara, H|Takagane, A|Abe, K|Araya, M|Irinoda, T|Yonezawa, H|Nakaya, T|Oyama, K|Takahashi, M|Saito, K
PMID: 12460781
21.
Journal: Jpn J Cancer Res. 2002 Dec;93(12):1342-50.
Title: Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
Author: Fujiwara, Hisataka|Terashima, Masanori|Irinoda, Takashi|Takagane, Akinori|Abe, Kaoru|Kashiwaba, Masahiro|Oyama, Kennichi|Takahashi, Masanori|Maesawa, Chihaya|Saito, Kazuyoshi|Takechi, Teiji|Fukushima, Masakazu
PMID: 12495474
22.
Journal: Cancer Chemother Pharmacol. 2003 Mar;51(3):240-6.
Title: Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.
Author: Terashima, Masanori|Irinoda, Takashi|Kawamura, Hidenobu|Takagane, Akinori|Abe, Kaoru|Oyama, Kenichi|Fujiwara, Hisataka|Saito, Kazuyoshi|Gotoh, Mitsukazu|Shirasaka, Tetsuhiko
PMID: 12655443
23.
Journal: Gastric Cancer. 2003;6 Suppl 1:2-8.
Title: S-1 in gastric cancer: a comprehensive review.
Author: Maehara, Yoshihiko
PMID: 12775012
24.
Journal: Gastric Cancer. 2003;6 Suppl 1:66-70.
Title: Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Author: Usuki, Hisashi|Ishimura, Ken|Yachida, Shinichi|Hagiike, Masanobu|Okano, Keiichi|Izuishi, Kunihiko|Karasawa, Yukihiko|Goda, Fuminori|Maeta, Hajime
PMID: 12775023
25.
Journal: Gastric Cancer. 2003;6 Suppl 1:71-81.
Title: Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Author: Terashima, Masanori|Fujiwara, Hisataka|Takagane, Akinori|Abe, Kaoru|Irinoda, Takashi|Nakaya, Tsutomu|Yonezawa, Hitoshi|Oyama, Kenichi|Saito, Kazuyoshi|Kanzaki, Norio|Ohtani, Satoshi|Nemoto, Tsuyoshi|Hoshino, Yutaka|Kogure, Michihiko|Gotoh, Mitsukazu
PMID: 12775024
26.
Journal: Gastric Cancer. 2003;6 Suppl 1:82-9.
Title: Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study.
Author: Yoshida, Kazuhiro|Tanabe, Kazuaki|Ueno, Hideaki|Ohta, Kouji|Hihara, Jun|Toge, Tetsuya|Nishiyama, Masahiko
PMID: 12775025
27.
Journal: Suppl Tumori. 2003 Sep-Oct;2(5):S19-22.
Title: Pharmacogenetics of stomach cancer.
Author: Toffoli, Giuseppe|Cecchin, Erika
PMID: 12914384
28.
Journal: Br J Cancer. 2003 Sep 1;89(5):816-20.
Title: Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil.
Author: Yamada, Y|Hamaguchi, T|Goto, M|Muro, K|Matsumura, Y|Shimada, Y|Shirao, K|Nagayama, S
PMID: 12942110
29.
Journal: Gan To Kagaku Ryoho. 2003 Sep;30(9):1297-301.
Title: [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
Author: Arai, Kuniyoshi|Iwasaki, Yoshiaki|Kimura, Yutaka|Takahashi, Keiichi|Yamaguchi, Tatsuro|Honma, Shigenori|Takahashi, Toshio
PMID: 14518409
30.
Journal: Eur J Cancer. 2003 Nov;39(16):2387-94.
Title: Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.
Author: Fujiwara, H|Terashima, M|Irinoda, T|Takagane, A|Abe, K|Nakaya, T|Yonezawa, H|Oyama, K|Takahashi, M|Saito, K|Takechi, T|Fukushima, M|Shirasaka, T
PMID: 14556932
31.
Journal: Oncol Rep. 2004 Jan;11(1):9-15.
Title: Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
Author: Tahara, Makoto|Ochiai, Atsuhi|Fujimoto, Junya|Boku, Narikazu|Yasui, Wataru|Ohtsu, Atsushi|Tahara, Eiichi|Yoshida, Shigeaki
PMID: 14654896
32.
Journal: Dig Dis Sci. 2004 Jan;49(1):60-4.
Title: Differences in dihydropyrimidine dehydrogenase activities between gastric and colorectal cancer.
Author: Nakata, Bunzo|Muguruma, Kazuya|Yamagata, Shigehito|Yukimoto, Kiyotaka|Maeda, Kiyoshi|Nishiguchi, Yukio|Ohira, Masaichi|Kato, Yasuyuki|Hirakawa, Kosei
PMID: 14992436
33.
Journal: Oncol Rep. 2004 May;11(5):1045-51.
Title: Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.
Author: Hotta, Tsukasa|Taniguchi, Katsutoshi|Kobayashi, Yasuhito|Johata, Kiyofumi|Sahara, Masaki|Naka, Teiji|Watanabe, Takashi|Ochiai, Minoru|Tanimura, Hiroshi|Tsubota, Yukari T
PMID: 15069545
34.
Journal: Oncol Rep. 2004 Jun;11(6):1233-9.
Title: Preoperative endoscopic analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in gastrointestinal cancer.
Author: Hotta, Tsukasa|Taniguchi, Katsutoshi|Kobayashi, Yasuhito|Johata, Kiyofumi|Sahara, Masaki|Naka, Teiji|Watanabe, Takashi|Ochiai, Minoru|Tanimura, Hiroshi|Tsubota, Yukari T
PMID: 15138561
35.
Journal: Eur J Cancer. 2004 Jul;40(10):1566-71.
Title: The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
Author: Nishina, Tomohiro|Hyodo, Ichinosuke|Miyaike, Jiro|Inaba, Tomoki|Suzuki, Seiyuu|Shiratori, Yasushi
PMID: 15196541
36.
Journal: Gastric Cancer. 2004;7(2):110-6.
Title: Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
Author: Sakurai, Yoichi|Uraguchi, Takashi|Imazu, Hiroki|Hasegawa, Shigeru|Matsubara, Toshiki|Ochiai, Masahiro|Funabiki, Takahiko
PMID: 15224198
37.
Journal: Int J Cancer. 2004 Dec 20;112(6):967-73.
Title: Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer.
Author: Ichikawa, Wataru|Takahashi, Takehiro|Suto, Kenichi|Nihei, Zenro|Shirota, Yoshinori|Shimizu, Michio|Sasaki, Yasutsuna|Hirayama, Renzo
PMID: 15316940
38.
Journal: Anticancer Res. 2004 Jul-Aug;24(4):2455-63.
Title: Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Author: Toriumi, Fumiki|Kubota, Tetsuro|Saikawa, Yoshiro|Yoshida, Masashi|Otani, Yoshihide|Watanabe, Masahiko|Kumai, Koichiro|Kitajima, Masaki
PMID: 15330198
39.
Journal: Anticancer Res. 2004 Jul-Aug;24(4):2495-501.
Title: Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
Author: Hisamitsu, Kazunori|Tsujitani, Shunichi|Yamaguchi, Kenichi|Fukuda, Kenji|Konishi, Ichiro|Kaibara, Nobuaki
PMID: 15330204
40.
Journal: Br J Cancer. 2004 Oct 4;91(7):1245-50.
Title: Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer.
Author: Ichikawa, W|Takahashi, T|Suto, K|Yamashita, T|Nihei, Z|Shirota, Y|Shimizu, M|Sasaki, Y|Hirayama, R
PMID: 15354215
41.
Journal: Oncol Rep. 2004 Nov;12(5):973-8.
Title: Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.
Author: Yamagata, Shigehito|Nakata, Bunzo|Hirakawa, Kosei
PMID: 15492780
42.
Journal: Gan To Kagaku Ryoho. 2005 Feb;32(2):183-7.
Title: [Assessment of dihydropyrimidine dehydrogenase and thymidylate synthase expression in gastric carcinoma and colonic carcinoma].
Author: Yoshida, Toru|Shimooki, Osamu|Baba, Yuko|Abe, Tadashi|Sugai, Tamotsu|Nakamura, Shin-ichi
PMID: 15751630
43.
Journal: Clin Cancer Res. 2005 Apr 15;11(8):3025-31.
Title: Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.
Author: Napieralski, Rudolf|Ott, Katja|Kremer, Markus|Specht, Katja|Vogelsang, Holger|Becker, Karen|Muller, Martina|Lordick, Florian|Fink, Ulrich|Rudiger Siewert, Jorg|Hofler, Heinz|Keller, Gisela
PMID: 15837757
44.
Journal: Anticancer Res. 2005 Jul-Aug;25(4):2997-3001.
Title: Clinical application of immunoreactivity of dihydropyrimidine dehydrogenase (DPD) in gastric scirrhous carcinoma treated with S-1, a new DPD inhibitory fluoropyrimidine.
Author: Shimizu, Toshio|Yamada, Yasuhide|Yasui, Hisateru|Shirao, Kuniaki|Fukuoka, Masahiro
PMID: 16080558
45.
Journal: Onkologie. 2005 Nov;28(11):589-92.
Title: Pharmacogenetics of extraordinary responses to 5-FU/cisplatin chemotherapy in advanced gastric cancer -- report of 2 cases.
Author: Wolschke, Christine|Goekkurt, Eray|Al-Batran, Salah-Eddin|Hossfeld, Dieter Kurt|Stoehlmacher, Jan
PMID: 16249645
46.
Journal: J Exp Clin Cancer Res. 2005 Sep;24(3):457-62.
Title: Level of 5-fluorodeoxyuridine 5'-monophosphate in cancerous tissue in patients with gastric cancer under preoperative administration of TS-1. A preliminary study.
Author: Yamamoto, S|Kubota, K
PMID: 16270533
47.
Journal: Anticancer Res. 2005 Nov-Dec;25(6A):3755-61.
Title: Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer.
Author: Nakayama, Yoshifumi|Inoue, Yuzuru|Nagashima, Nobuo|Katsuki, Takefumi|Matsumoto, Kentarou|Kadowaki, Koji|Shibao, Kazunori|Tsurudome, Yosuke|Hirata, Keiji|Sako, Tatsuhiko|Nagata, Naoki|Itoh, Hideaki
PMID: 16302736
48.
Journal: Gan To Kagaku Ryoho. 2005 Oct;32(11):1748-51.
Title: [A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function].
Author: Yamamoto, Kazuyoshi|Imamura, Hiroshi|Furukawa, Hiroshi|Kishimoto, Tomono|Tanaka, Junichi|Oshiro, Ryota|Tatsuta, Masayuki|Masutani, Seizo|Fukunaga, Mutsumi|Nakayama, Takahiro|Takemoto, Hiroyoshi|Kondo, Motoi|Kamigaki, Shunji|Kawasaki, Takatoshi
PMID: 16315929
49.
Journal: Nagoya J Med Sci. 2005 Jun;67(3-4):117-24.
Title: Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese.
Author: Tanaka, Daisuke|Hishida, Asahi|Matsuo, Keitaro|Iwata, Hiroji|Shinoda, Masayuki|Yamamura, Yoshitaka|Kato, Tomoyuki|Hatooka, Shunzo|Mitsudomi, Tetsuya|Kagami, Yoshitoyo|Ogura, Michinori|Tajima, Kazuo|Suyama, Motokazu|Naito, Mariko|Yamamoto, Kazuhito|Tamakos
PMID: 17375478
50.
Journal: Int J Cancer. 2006 Aug 15;119(4):783-91.
Title: Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
Author: Wada, Yoshiyuki|Yoshida, Kazuhiro|Suzuki, Takahisa|Mizuiri, Hirozumi|Konishi, Kazuo|Ukon, Kei|Tanabe, Kazuaki|Sakata, Yu|Fukushima, Masakazu
PMID: 16557585
51.
Journal: Anticancer Res. 2006 Mar-Apr;26(2B):1455-62.
Title: A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
Author: Rino, Yasushi|Takanashi, Yoshinori|Yukawa, Norio|Saeki, Hiroyuki|Wada, Hiroo|Kanari, Masahiro|Yamada, Roppei|Satoh, Tsutomu|Yamamoto, Naoto|Imada, Toshio
PMID: 16619558
52.
Journal: Korean J Intern Med. 2006 Mar;21(1):43-5.
Title: Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency.
Author: Baek, Jin Ho|Kim, Jong Gwang|Kim, Shi Nae|Kim, Dong Hwan|Sohn, Sang Kyun|Hong, Young Jun|Lee, Kyu Bo
PMID: 16646564
53.
Journal: Gan To Kagaku Ryoho. 2006 May;33(5):625-9.
Title: [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Author: Uyama, Ryo|Yoshizawa, Yasuo|Tajiri, Takuma|Endo, Yutaka|Mitsuya, Toshiyuki|Sanada, Yutaka
PMID: 16685161
54.
Journal: Int J Cancer. 2006 Oct 15;119(8):1927-33.
Title: Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1.
Author: Ichikawa, Wataru|Takahashi, Takehiro|Suto, Kenichi|Shirota, Yoshinori|Nihei, Zenro|Shimizu, Michio|Sasaki, Yasutsuna|Hirayama, Renzo
PMID: 16736497
55.
Journal: Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:37-41.
Title: [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Author: Yamada, Yasuhide
PMID: 16897970
56.
Journal: Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:83-6.
Title: [Combination chemotherapy of S-1 and docetaxel on advanced and recurrent gastric cancer].
Author: Yoshida, Kazuhiro|Wada, Yoshiyuki|Tanabe, Kazuaki|Ukon, Kei|Hihara, Jyun
PMID: 16897978
57.
Journal: Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:117-20.
Title: Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
Author: Ajani, Jaffer A
PMID: 16897985
58.
Journal: Ai Zheng. 2006 Aug;25(8):1039-43.
Title: [Correlative analysis between serum dihydropyrimidine dehydrogenase, activity, concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients].
Author: Peng, Rou-Jun|Dong, Qiu-Mei|Shi, Yan-Xia|Cao, Ye|Zhou, Zhong-Mei|Yuan, Zhong-Yu|Li, Su|Li, Hai|Jiang, Wen-Qi
PMID: 16965690
59.
Journal: Oncol Rep. 2006 Oct;16(4):721-7.
Title: Expression of chemoresistance-related proteins in alpha-fetoprotein-producing adenocarcinoma of the digestive organs.
Author: Kamoshida, Shingo|Suzuki, Mai|Sakurai, Yoichi|Ochiai, Masahiro|Kimura, Fumikazu|Kuwao, Sadahito|Sakamoto, Kazuki|Sugimoto, Yoshikazu|Fukushima, Masakazu|Tsutsumi, Yutaka
PMID: 16969485
60.
Journal: Oncol Rep. 2006 Dec;16(6):1165-72.
Title: The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
Author: Oeda, Mamoru|Yoshida, Kazuhiro|Sanada, Yuichi|Wada, Yoshiyuki|Suzuki, Takahisa|Mizuiri, Hirozumi|Konishi, Kazuo|Shigematsu, Hideo|Tanabe, Kazuaki|Fukushima, Masakazu
PMID: 17089033
61.
Journal: Adv Exp Med Biol. 2006;587:115-20.
Title: Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
Author: Hofler, Heinz|Langer, Rupert|Ott, Katja|Keller, Gisela
PMID: 17163161
62.
Journal: Cancer Lett. 2007 Jul 18;252(2):307-13. Epub 2007 Feb 15.
Title: Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
Author: Kodera, Yasuhiro|Ito, Seiji|Fujiwara, Michitaka|Mochizuki, Yoshinari|Nakayama, Goro|Ohashi, Norifumi|Koike, Masahiko|Yamamura, Yoshitaka|Nakao, Akimasa
PMID: 17303323
63.
Journal: Cancer Chemother Pharmacol. 2007 Aug;60(3):437-46.
Title: Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
Author: Fakhrejahani, Elham|Miyamoto, Akiko|Tanigawa, Nobuhiko
PMID: 17377791
64.
Journal: Zhonghua Nei Ke Za Zhi. 2007 Feb;46(2):103-6.
Title: [The association between DPYD gene polymorphism and chemotherapeutic toxicity of 5-FU in gastric carcinoma and colonic carcinoma].
Author: Zhang, Hong|Li, You-ming|Yu, Chao-hui|Wang, Sheng-qi|Ji, Feng|Chen, Chun-xiao
PMID: 17445431
65.
Journal: Med Oncol. 2007;24(2):251-8.
Title: DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU: results from genotyping study on 75 gastric carcinoma and colon carcinoma patients.
Author: Zhang, Hong|Li, You-ming|Zhang, Hao|Jin, Xi
PMID: 17848752
66.
Journal: Gan To Kagaku Ryoho. 2007 Oct;34(10):1581-7.
Title: [Orotate phosphoribosyltransferase levels in gastric carcinoma and normal gastric mucosa - correlation with thymidylate synthase and dihydropyrimidine dehydrogenase levels and the changes after neoadjuvant chemotherapy].
Author: Sakurai, Yoichi|Furuta, Shinpei|Sunagawa, Risaburo|Tonomura, Shuhei|Inaba, Kazuki|Shoji, Mitsutaka|Nakamura, Yasuko|Isogaki, Jun|Komori, Yoshiyuki|Uyama, Ichiro|Kamoshida, Shingo|Tsutsumi, Yutaka
PMID: 17940372
67.
Journal: J Gastroenterol. 2007 Oct;42(10):816-22.
Title: Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism.
Author: Sasaki, Eiji|Tominaga, Kazunari|Kuwamura, Hikaru|Watanabe, Toshio|Fujiwara, Yasuhiro|Oshitani, Nobuhide|Higuchi, Kazuhide|Arakawa, Tetsuo
PMID: 17940834
68.
Journal: Gastrointest Cancer Res. 2007 Sep;1(5):171-6.
Title: Thymidylate synthase gene expression in primary tumors predicts activity of s-1-based chemotherapy for advanced gastric cancer.
Author: Takiuchi, Hiroya|Kawabe, Shin-Ichiro|Gotoh, Masahiro|Katsu, Ken-Ichi
PMID: 19262706
69.
Journal: Br J Cancer. 2008 Feb 26;98(4):832-9.
Title: Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.
Author: Matsubara, J|Nishina, T|Yamada, Y|Moriwaki, T|Shimoda, T|Kajiwara, T|Nakajima, T E|Kato, K|Hamaguchi, T|Shimada, Y|Okayama, Y|Oka, T|Shirao, K
PMID: 18231104
70.
Journal: Cancer Chemother Pharmacol. 2008 Dec;63(1):85-9.
Title: High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
Author: Kuramochi, Hidekazu|Hayashi, Kazuhiko|Uchida, Kazumi|Nakajima, Go|Hatori, Takashi|Danenberg, Kathleen D|Danenberg, Peter V|Yamamoto, Masakazu
PMID: 18309485
71.
Journal: Ann Surg Oncol. 2008 Aug;15(8):2301-9.
Title: Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
Author: Sakurai, Yoichi|Yoshida, Ikuo|Kamoshida, Shingo|Inaba, Kazuki|Isogaki, Jun|Komori, Yoshiyuki|Uyama, Ichiro|Tsutsumi, Yutaka
PMID: 18506536
72.
Journal: J Surg Oncol. 2008 Aug 1;98(2):130-4.
Title: Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.
Author: Grau, Juan J|Caballero, Miguel|Monzo, Mariano|Munoz-Garcia, Carmen|Domingo-Domenech, Jose|Navarro, Alfons|Conill, Carlos|Campayo, Marc|Bombi, Jose A
PMID: 18537153
73.
Journal: Int J Clin Oncol. 2008 Jun;13(3):212-9.
Title: Challenge for a better combination with basic evidence.
Author: Yoshida, Kazuhiro|Yamaguchi, Kazuya|Osada, Shinji|Kawaguchi, Yoshihiro|Takahashi, Takao|Sakashita, Fumio|Tanaka, Yoshihiro
PMID: 18553230
74.
Journal: Anticancer Res. 2008 May-Jun;28(3A):1593-602.
Title: Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts.
Author: Sakurai, Yoichi|Yoshida, Ikuo|Kamoshida, Shingo|Inaba, Kazuki|Isogaki, Jun|Komori, Yoshiyuki|Uyama, Ichiro|Tsutsumi, Yutaka
PMID: 18630517
75.
Journal: Anticancer Drugs. 2008 Sep;19(8):819-24.
Title: Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
Author: Koizumi, Wasaburo|Okayasu, Isao|Hyodo, Ichinosuke|Sakamoto, Junichi|Kojima, Hiroshi
PMID: 18690094
76.
Journal: Int J Mol Med. 2008 Dec;22(6):709-16.
Title: Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
Author: Fukui, Yousuke|Oka, Toshinori|Nagayama, Sekio|Danenberg, Peter V|Danenberg, Kathleen D|Fukushima, Masakazu
PMID: 19020767
77.
Journal: Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1882-6.
Title: The discrepancy in thymidylate synthase and dihydropyrimidine dehydrogenase expression depending on measurement methodologies in stage 4 gastric cancer.
Author: Akamoto, Shintaro|Usuki, Hisashi|Haba, Reiji|Kakinoki, Keitarou|Okano, Keiichi|Izuishi, Kunihiko|Wakabayashi, Hisao|Suzuki, Yasuyuki
PMID: 19102414
78.
Journal: Toxicology. 2009 Feb 4;256(1-2):135-40.
Title: Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma.
Author: Wang, Jun|Liu, Wei|Zhao, Qing|Qi, Qi|Lu, Na|Yang, Yong|Nei, Fei-Fei|Rong, Jing-Jing|You, Qi-Dong|Guo, Qing-Long
PMID: 19084572
79.
Journal: Int J Oncol. 2009 Mar;34(3):787-96.
Title: Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer.
Author: Jeung, Hei Cheul|Rha, Sun Young|Park, Chan Hee|Im, Chong-Kun|Shin, Sang Joon|Ahn, Joong Bae|Noh, Sung Hoon|Roh, Jae Kyung|Chung, Hyun Cheol
PMID: 19212683
80.
Journal: Br J Cancer. 2009 Mar 10;100(5):732-8.
Title: Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Author: Kim, J-S|Kim, M-A|Kim, T M|Lee, S-H|Kim, D-W|Im, S-A|Kim, T-Y|Kim, W H|Yang, H-K|Heo, D S|Bang, Y-J|Lee, K-U|Choe, K-J|Kim, N K
PMID: 19259093
81.
Journal: Gan To Kagaku Ryoho. 2010 Jan;37(1):131-3.
Title: [Severe bone marrow suppression during adjuvant chemotherapy for gastric cancer by S-1 and its possible relationship to dihydropyrimidine dehydrogenase deficiency].
Author: Aragane, Hideki|Suchi, Kentaro|Shimomura, Masanori|Katano, Tomoko|Yasui, Hitoshi|Kan, Keitaro
PMID: 20087047
82.
Journal: Toxicol Lett. 2010 Sep 1;197(3):201-10.
Title: Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism.
Author: Zhao, Qing|Wang, Jia|Zou, Mei-Juan|Hu, Rong|Zhao, Li|Qiang, Lei|Rong, Jing-Jing|You, Qi-Dong|Guo, Qing-Long
PMID: 20570612
83.
Journal: Cancer Res Treat. 2010 Jun;42(2):118-20.
Title: A case of 5-fluorouracil induced encephalopathy.
Author: Kwon, Kyung A|Kwon, Hyuk-Chan|Kim, Min Chan|Kim, Sung-Hyun|Oh, Sung Yong|Lee, Suee|Kim, Hyo-Jin
PMID: 20622967
84.
Journal: Chemotherapy. 2010;56(4):313-7.
Title: Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity.
Author: Kim, Suk-Ran|Park, Chang-Hun|Park, Silvia|Park, Joon-Oh|Lee, Jeeyun|Lee, Soo-Youn
PMID: 20714149
85.
Journal: World J Gastroenterol. 2010 Sep 28;16(36):4575-82.
Title: A predictive factor for the response to S-1 plus cisplatin in gastric cancer.
Author: Miyazaki, Ikuko|Kawai, Takashi|Harada, Youji|Moriyasu, Fuminori
PMID: 20857529
86.
Journal: Anticancer Drugs. 2011 Sep;22(8):801-10.
Title: Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer.
Author: Jeung, Hei-Cheul|Rha, Sun Young|Shin, Sang Joon|Lim, Seung Joon|Roh, Jae Kyung|Noh, Sung Hoon|Chung, Hyun Cheol
PMID: 21572321
87.
Journal: Chin Med J (Engl). 2012 Mar;125(5):741-6.
Title: Polymorphisms of dihydropyrimidine dehydrogenase gene and clinical outcomes of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Author: Zhang, Xiao-ping|Bai, Zhi-bin|Chen, Bao-an|Feng, Ji-feng|Yan, Feng|Jiang, Zhi|Zhong, Yue-jiao|Wu, Jian-zhong|Chen, Lu|Lu, Zu-hong|Tong, Na|Zhang, Zheng-dong|Xu, Pei-pei|Peng, Miao-xin|Zhang, Wen-jing|Wang, Shuai
PMID: 22490566
88.
Journal: Gan To Kagaku Ryoho. 2012 Oct;39(10):1563-6.
Title: [A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP].
Author: Goto, Akira|Itoh, Miki|Wakasugi, Hideki|Kanno, Shinichi|Yabana, Takashi|Mitsuhashi, Kei|Adachi, Takeya|Kondo, Yoshihiro|Suzuki, Takashi|Shinomura, Yasuhisa
PMID: 23064073
89.
Journal: Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52.
Title: Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
Author: Cui, Yuehong|Li, Qian|Yu, Yiyi|Chen, Yong|Feng, Yi|Wang, Yan|Liu, Tianshu
PMID: 23064955
90.
Journal: Clin Transl Oncol. 2013 Aug;15(8):619-25.
Title: Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.
Author: Gao, J|He, Q|Hua, D|Mao, Y|Li, Y|Shen, L
PMID: 23263912
91.
Journal: Med Oncol. 2013 Jun;30(2):545.
Title: Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer.
Author: Moiseyenko, Vladimir M|Volkov, Nikita M|Suspistin, Evgeny N|Yanus, Grigoriy A|Iyevleva, Aglaya G|Kuligina, Ekatherina Sh|Togo, Alexandr V|Kornilov, Alexandr V|Ivantsov, Alexandr O|Imyanitov, Evgeny N
PMID: 23532817
92.
Journal: Oncol Rep. 2013 Dec;30(6):2845-51.
Title: Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
Author: Mekata, Eiji|Murata, Satoshi|Sonoda, Hiromichi|Shimizu, Tomoharu|Umeda, Tomoko|Shiomi, Hisanori|Naka, Shigeyuki|Yamamoto, Hiroshi|Abe, Hajime|Edamatsu, Takeo|Fujieda, Ayako|Fujioka, Masaki|Wada, Tsutomu|Tani, Tohru
PMID: 24100378
93.
Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Aug;33(8):1098-101.
Title: [Effect of jianpi liqi recipe on mRNA expressions of TP, DPD, and CYP3A4 in mice with human gastric cancer transplanted tumor].
Author: Huang, Ting|Yang, Xue-fei|Li, Yong|Zhang, Zhi-di|Huang, Ling|Zhang, Jian-gang|Zhang, Xiao-li
PMID: 24325062
94.
Journal: Zhonghua Yi Xue Za Zhi. 2014 Jan 14;94(2):127-30.
Title: [Correlated analysis of 5 fluorouracil metabolic enzymes with tumor response after SOX regimen neoadjuvant chemotherapy in advanced gastric cancer].
Author: Li, Tao|Liang, Meixia|Yuan, Jing|Guo, Xu|Feng, Daofu|Li, Ting|Teng, Da|Peng, Zheng|Wu, Xin|Li, Zexue|Wang, Hua|Chen, Lin
PMID: 24721353
95.
Journal: Gastric Cancer. 2015 Apr;18(2):262-70.
Title: Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.
Author: Naruke, Akira|Azuma, Mizutomo|Takeuchi, Atsuko|Ishido, Kenji|Katada, Chikatoshi|Sasaki, Tohru|Higuchi, Katsuhiko|Tanabe, Satoshi|Saegusa, Makoto|Koizumi, Wasaburo
PMID: 24651981
96.
Journal: Gastric Cancer. 2015 Jul;18(3):538-48.
Title: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer.
Author: Sasako, Mitsuru|Terashima, Masanori|Ichikawa, Wataru|Ochiai, Atsushi|Kitada, Koji|Kurahashi, Issei|Sakuramoto, Shinichi|Katai, Hitoshi|Sano, Takeshi|Imamura, Hiroshi
PMID: 25112781
97.
Journal: Cell Biochem Biophys. 2015 Apr;71(3):1653-61.
Title: Relationship Between the DPD and TS mRNA Expression and the Response to S-1-Based Chemotherapy and Prognosis in Patients with Advanced Gastric Cancer.
Author: Shen, Xiao-Ming|Zhou, Chong|Lian, Lian|Li, Li-Qun|Li, Wei|Tao, Min
PMID: 25388847
98.
Journal: PLoS One. 2015 Mar 20;10(3):e0120324.
Title: Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer.
Author: Kim, Ji-Yeon|Shin, Eun|Kim, Jin Won|Lee, Hye Seung|Lee, Dae-Won|Kim, Se-Hyun|Lee, Jeong-Ok|Kim, Yu Jung|Kim, Jee Hyun|Bang, Soo-Mee|Ahn, Sang-Hoon|Park, Do Joong|Lee, Jong Seok|Lee, Ju-Seog|Kim, Hyung-Ho|Lee, Keun-Wook
PMID: 25793299
99.
Journal: Case Rep Gastrointest Med. 2015;2015:685459.
Title: Osteogenesis imperfecta, pseudoachalasia, and gastric cancer.
Author: Mizrak, Dilsa|Alkan, Ali|Erdogdu, Batuhan|Utkan, Gungor
PMID: 25874139
100.
Journal: Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):28-34.
Title: [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Author: Wan, Yiyuan|Hui, Hongxia|Wang, Xiaowei|Wu, Jian|Sun, Su'an
PMID: 26796803
101.
Journal: Int J Biol Markers. 2016 May 28;31(2):e101-9.
Title: High/positive expression of 5-fluorouracil metabolic enzymes predicts better response to S-1 in patients with gastric cancer: a meta-analysis.
Author: Wang, Dan|Yu, Xuejun|Wang, Xiuwen
PMID: 27012156
102.
Journal: Oncotarget. 2016 Aug 23;7(34):55449-55457.
Title: ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.
Author: Li, Ziyu|Xing, Xiaofang|Shan, Fei|Li, Shuangxi|Li, Zhongwu|Xiao, Aitang|Xing, Zhaodong|Xue, Kan|Li, Zhemin|Hu, Ying|Jia, Yongning|Miao, Rulin|Zhang, Lianhai|Bu, Zhaode|Wu, Aiwen|Ji, Jiafu
PMID: 27487151
103.
Journal: Cancer Chemother Pharmacol. 2017 Jan;79(1):69-79.
Title: Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway.
Author: He, Ming-Ming|Zhang, Dong-Sheng|Wang, Feng|Wang, Zi-Xian|Yuan, Shu-Qiang|Wang, Zhi-Qiang|Luo, Hui-Yan|Ren, Chao|Qiu, Miao-Zhen|Jin, Ying|Wang, De-Shen|Chen, Dong-Liang|Zeng, Zhao-Lei|Li, Yu-Hong|He, Yang-Yang|Hao, Yuan-Tao|Guo, Pi|Wang, Feng-Hua|Zeng, Yi-
PMID: 27913881
104.
Journal: Pharmacogenomics J. 2017 Oct;17(5):441-451.
Title: Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies.
Author: Meulendijks, D|Rozeman, E A|Cats, A|Sikorska, K|Joerger, M|Deenen, M J|Beijnen, J H|Schellens, J H M
PMID: 27995989
105.
Journal: Dis Markers. 2017;2017:9202676.
Title: The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis.
Author: Zhang, Cong|Liu, Hongpeng|Ma, Bin|Song, Yongxi|Gao, Peng|Xu, Yingying|Yu, Dehao|Wang, Zhenning
PMID: 28255193
106.
Journal: Ann Oncol. 2017 Dec 1;28(12):2915-2922.
Title: DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update.
Author: Henricks, L M|Opdam, F L|Beijnen, J H|Cats, A|Schellens, J H M
PMID: 29045513
107.
Journal: Cancer Lett. 2018 Jan 1;412:208-215.
Title: Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial.
Author: Das, Kakoli|Taguri, Masataka|Imamura, Hiroshi|Sugimoto, Naotoshi|Nishikawa, Kazuhiro|Yoshida, Kazuhiro|Tan, Patrick|Tsuburaya, Akira
PMID: 29061504
108.
Journal: Acta Biochim Pol. 2018;65(2):227-234.
Title: TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A gene mutation in Mexican colorectal cancer patients.
Author: Gallegos-Arreola, Martha Patricia|Zuniga-Gonzalez, Guillermo Moises|Sanchez-Lopez, Josefina Yoaly|Cruz, Alondra Yeraldi Naranjo|Peralta-Leal, Valeria|Figuera, Luis Eduardo|Puebla-Perez, Ana Maria|Ronquillo-Carreon, Carlos Alberto|Puebla-Mora, Ana Graciela
PMID: 29906295